Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2005 filings

All 61 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2005, sourced directly from the official regulator.

61 Filings
2005 Period
2005 filings (61)
Filing Released Lang
Change of Director's Interest Notice x 5 10 pages ?Kb
Director's Dealing
2005-12-22 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2005-12-21 English
Completes $15 million Raising 2 pages ?Kb
Capital/Financing Update
2005-12-19 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2005-12-15 English
Letter to Shareholders re Share Purchase Plan 7 pages ?Kb
Capital/Financing Update
2005-11-24 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2005-11-16 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2005-11-16 English
Notice under Section 708A 1 page ?Kb
Capital/Financing Update
2005-11-16 English
AGM Presentations 27 pages ?Kb
AGM Information
2005-11-15 English
Notice of Extraordinary General Meeting 8 pages ?Kb
Share Issue/Capital Change
2005-11-14 English
Raises A$15m Through Institutional Placement & SPP 2 pages ?Kb
Capital/Financing Update
2005-11-13 English
Reinstatement to Official Quotation 1 page ?Kb
Regulatory Filings
2005-11-13 English
Suspension from Official Quotation 1 page ?Kb
Regulatory Filings
2005-11-10 English
US Associate DNT receives Technology Innovation Award 3 pages ?Kb
Regulatory Filings
2005-11-09 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-11-08 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-10-30 English
Market update - correction 2 pages ?Kb
Regulatory Filings
2005-10-30 English
Becoming a substantial holder 3 pages ?Kb
Major Shareholding Notification
2005-10-17 English
Market Update October 2005 23 pages ?Kb
Investor Presentation
2005-10-13 English
Notice of Annual General Meeting 7 pages ?Kb
AGM Information
2005-10-12 English
Replacement Form - Appendix 3B 8 pages ?Kb
Capital/Financing Update
2005-10-12 English
Replacement Page - Annual Report 2 pages ?Kb
Regulatory Filings
2005-10-12 English
Becoming a substantial holder 14 pages ?Kb
Major Shareholding Notification
2005-10-11 English
Secures full ownership of core technology 2 pages ?Kb
Capital/Financing Update
2005-10-10 English
US Associate DNT Major Collaboration with NCL 5 pages ?Kb
Regulatory Filings
2005-10-10 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update
2005-10-10 English
Notice under Section 708A 1 page ?Kb
Share Issue/Capital Change
2005-10-10 English
VivaGel development accelerated with US$20m funding from NIH 3 pages ?Kb
Capital/Financing Update
2005-10-02 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-09-29 English
2005 Annual Report 100 pages ?Kb
Regulatory Filings
2005-09-28 English
Response to market speculation 2 pages ?Kb
Capital/Financing Update
2005-09-28 English
Response to ASX Query re Share Price 4 pages ?Kb
Regulatory Filings
2005-09-27 English
SPL Investee Company Dimerix Closes Series A Financing 3 pages ?Kb
Capital/Financing Update
2005-09-14 English
Preliminary Final Report & Commentary 17 pages ?Kb
Annual Report
2005-09-05 English
Biotech Expo Presentation 18 pages ?Kb
Investor Presentation
2005-08-08 English
Receives Frost & Sullivan Growth & Strategy Leadership Award 4 pages ?Kb
Regulatory Filings
2005-08-03 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Regulatory Filings
2005-07-27 English
Appendix 3B - Employee Share Options 9 pages ?Kb
Regulatory Filings
2005-07-13 English
Starpharma investee company DNT-new low cost nanostructures 5 pages ?Kb
Regulatory Filings
2005-05-18 English
Investee Company Dimerix Bioscience offered Grant 4 pages ?Kb
Regulatory Filings
2005-05-10 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Regulatory Filings
2005-04-27 English
Expiry of Options 1 page ?Kb
Regulatory Filings
2005-04-07 English
Market Update 17 pages ?Kb
Regulatory Filings
2005-04-03 English
To receive up to $5.6m grant for product development 2 pages ?Kb
Regulatory Filings
2005-03-31 English
Appointment of COO 2 pages ?Kb
Regulatory Filings
2005-03-29 English
DNT appoints Dow Licensing Executive to Board of Directors 3 pages ?Kb
Regulatory Filings
2005-03-28 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-03-22 English
Change of Director's Interest Notice x 3 6 pages ?Kb
Director's Dealing
2005-03-20 English
Launches New Start-Up Biotechnology Company 2 pages ?Kb
Regulatory Filings
2005-03-15 English
QPX' ann: Launches Start Up Biotechnology Company 3 pages ?Kb
Regulatory Filings
2005-03-15 English
SPL & Industrial Research Ltd establish JV 3 pages ?Kb
Regulatory Filings
2005-03-02 English
Half Yearly Report & Half Year Accounts 21 pages ?Kb
Interim / Quarterly Report
2005-02-23 English
Investor Update 33 pages ?Kb
Regulatory Filings
2005-01-31 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-01-30 English
ADRs added to Nanosphere List of Leading Nano Stocks 2 pages ?Kb
Regulatory Filings
2005-01-27 English
Reinstatement to Official Quotation 1 page ?Kb
Regulatory Filings
2005-01-26 English
DNT/Dow & SPL sign major 3-way deal to comm nanotechnology 3 pages ?Kb
Capital/Financing Update
2005-01-26 English
Suspension from Official Quotation 1 page ?Kb
Regulatory Filings
2005-01-23 English
Responding to Article in The Age Newspaper 1 page ?
Capital/Financing Update
2005-01-23 English
Trading Halt 1 page ?Kb
Regulatory Filings
2005-01-19 English
Completion of Level 1 American Depository Receipts Program 2 pages ?Kb
Capital/Financing Update
2005-01-12 English